Home › Funds › Lion Point Capital, LP › BHVN

Lion Point Capital, LP position in BHVN

BIOHAVEN LTD · Health Care

Lion Point Capital, LP reported holding 51,700 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$769K, representing 3.68% of its reported portfolio and ranking #10 among its reported holdings. Lion Point Capital, LP has disclosed BHVN holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)51.70K sh
Reported value held$769.30K
Portfolio Weight3.68%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lion Point Capital, LP's BHVN position evolved

Lion Point Capital, LP first disclosed a stake in BHVN in Q3 2024 at 35,400 shares (US$1.8M). Across 8 filings, Lion Point Capital, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 51,700 shares valued at US$769K. Notable position changes include a 36% trim in Q4 2024 (shares fell 36% over the following quarter), a 128% increase in Q4 2025 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 35.40K $1.77M New
Q4 2024 22.70K $847.85K Reduce
Q1 2025 22.70K $545.71K Hold
Q2 2025 22.70K $320.30K Hold
Q3 2025 22.70K $340.73K Hold
Q4 2025 51.70K $583.69K Add
Q1 2026 51.70K $437.38K Hold
Q2 2026 51.70K $769.30K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BHVN and 13F data

BHVN (BIOHAVEN LTD) is a Health Care company. 30 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BHVN

All BHVN fund holders →

FAQ

How long has Lion Point Capital, LP held BHVN?

Lion Point Capital, LP has disclosed BHVN holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Lion Point Capital, LP's current position in BHVN?

As of Q2 2026, Lion Point Capital, LP holds 51.70K shares of BHVN (BIOHAVEN LTD), valued at $769.30K, representing 3.68% of its reported portfolio and ranking #10.

Has Lion Point Capital, LP been buying or selling BHVN?

In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in BHVN.

Which other funds hold BHVN?

Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.